| Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology. | |
| | |
MedLine Citation:
|
PMID: 14764025 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The advent of positron emission tomography (PET) and PET/computed tomography (CT) now enables us to detect metabolically active gynecologic cancers with greater accuracy than was possible with anatomic imagings. Fluorine-18 fluorodeoxyglucose PET has been useful in differentiation of malignant from benign lymph nodes, and residual or recurrent cancers from post-treatment changes. PET/CT produces additional information for the diagnosis and tissue biopsy as well as radiotherapy planning. This paper reviews the principle and clinical utility of PET and PET/CT in the diagnosis, staging, recurrence, therapeutic response as well as prognosis of gynecologic cancers. |
| | |
Authors:
|
E E Kim |
Related Documents
:
|
20574705 - Contrast-enhanced mri and pet-ct in the evaluation of patients with suspected local rec... 17036525 - Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomogr... 18619385 - Imaging hodgkin and non-hodgkin lymphoma in the head and neck. 16330565 - 18f-fdg pet in detecting metastatic infectious disease. 9316055 - A magnetic resonance template for normal cerebellar development in the human fetus. 9442225 - High-intensity lesion on t1-weighted mr images in neurofibromatosis type 1: a case of p... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Volume: 14 ISSN: 1048-891X ISO Abbreviation: Int. J. Gynecol. Cancer Publication Date: 2004 Jan-Feb |
Date Detail:
|
Created Date: 2004-02-06 Completed Date: 2004-05-27 Revised Date: 2006-11-07 |
Medline Journal Info:
|
Nlm Unique ID: 9111626 Medline TA: Int J Gynecol Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 12-22 Citation Subset: IM |
Affiliation:
|
Division of Diagnostic Imaging, Department of Nuclear Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. ekim@di.mdacc.tmc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Fluorodeoxyglucose F18 / diagnostic use Genital Diseases, Female / diagnosis*, radiography, radionuclide imaging Humans Neoplasm Recurrence, Local / diagnosis*, radiography, radionuclide imaging Neoplasm Staging Radiopharmaceuticals / diagnostic use Tomography, Emission-Computed* Tomography, X-Ray Computed* |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The exploding worldwide cancer burden: the impact of cancer on women.
Next Document: The relative importance of surgical training and laboratory research in a gynecologic oncology fello...